Tech Company Financing Transactions
PK MED Funding Round
On 7/24/2024, PK MED announced $1.6 million in funding from Bpifrance.
Transaction Overview
Company Name
Announced On
7/24/2024
Transaction Type
Venture Equity
Amount
$1,600,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its project PKM-02, an innovative cell-homing technology aiming to enhance bone marrow transplantation in several diseases with high unmet medical need, such as leukemias and hemoglobinopathies.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
14 rue Jean Antoine de Baïf
Paris, 75013
France
Paris, 75013
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
PK MED specializes in the innovative development of custom-designed, injectable, and biodegradable micro-implants. Our expertise spans across critical healthcare domains, focusing on drug delivery systems for rheumatology and enhancing cell-homing techniques to improve bone marrow transplantation outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gauthier Pouliquen
Chief Financial Officer
Vincent Dagommer
VP - Bus. Development
Claire Naussac
VP - R & D
Charles Sanson
Browse more venture capital transactions:
Prev: 7/24/2024: Star Catcher venture capital transaction
Next: 7/24/2024: Clarapath venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs